3628 results for «2136»

Filter By

3628 results

EuroPCR 2025 Closing Ceremony

23 May 2025 – From EuroPCR 2025

Conclude your conference experience with the EuroPCR 2025 Closing Ceremony, celebrating the achievements, innovations, and advancements presented throughout the event, and setting the stage for future developments in interventional cardiology.

EuroPCR 2025 Closing Ceremony

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

21 May 2025 – From EuroPCR 2025

Celebrate innovation and research excellence in interventional cardiology with the Jon DeHaan Foundation Award and Michele Pighi Young Investigator Award session. This session highlights groundbreaking work and emerging talent shaping the future of cardiovascular interventions.

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

Andreas Grüntzig Ethica Award

22 May 2025 – From EuroPCR 2025

Recognize excellence in interventional cardiology with the prestigious Andreas Grüntzig Ethica Award. This session honors outstanding contributions and ethical standards that advance the field and improve patient care worldwide.

Andreas Grüntzig Ethica Award

EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome

22 May 2025 – From EuroPCR 2025

Mark the 20th anniversary of EuroIntervention with this special annual editorial meeting open to all EuroPCR participants. Reflect on the journal's achievements, discuss future directions, and engage with leaders in interventional cardiology to shape the evolving landscape of cardiovascular research and practice.

EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome

Refractory heart failure: combining oral therapy and device is key

21 May 2025 – From EuroPCR 2025

Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.

Refractory heart failure: combining oral therapy and device is key

Stent failure: don't guess, just see!

22 May 2025 – From EuroPCR 2025

Investigate causes and imaging-based solutions for stent failure in this session. Topics include management of refractory stent underexpansion using lithotripsy or stent ablation, OCT perspectives on iatrogenic aortic dissection during PCI for in-stent restenosis, and analyses of bioresorbable scaffold failure. Gain insights into complex stenting techniques...

Stent failure: don't guess, just see!

Peripheral interventions: the hidden key for complications

22 May 2025 – From EuroPCR 2025

Uncover the critical role of peripheral interventions in managing complications. This session shares case stories of lost stents, unusual TAVI access complications, percutaneous removal of misplaced devices, revascularisation of iatrogenic pseudoaneurysms, and challenges when multiple closure devices are insufficient.

Peripheral interventions: the hidden key for complications

Ultrasound renal denervation is now guideline-recommended: how do I get started?

20 May 2025 – From EuroPCR 2025

Ultrasound renal denervation (uRDN) is now guideline-recommended—are you ready to bring it into practice? This EuroPCR 2025 session offers everything you need to get started: review key results from Sham-controlled and off-medication trials confirming the efficacy and safety of RDN; understand why both the ESC and...

Ultrasound renal denervation is now guideline-recommended: how do I get started?

Valve choice - Shaping index procedures and lifetime patient management

22 May 2025 – From EuroPCR 2025

This session addresses recent advancements and ongoing challenges in transcatheter aortic valve implantation (TAVI), with a particular focus on valve selection during index procedures. Presentations include data from the Accurate IDE trial, highlighting the prognostic implications of valve underexpansion. A clinical case involving an 80-year-old patient with severe...

Valve choice - Shaping index procedures and lifetime patient management

How to manage coronary artery disease in TAVI candidates?

20 May 2025 – From EuroPCR 2025

Understand the comprehensive management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI). This session reviews evidence-based evaluation, decision-making, and treatment strategies for significant coronary lesions, including severe left main and multivessel disease, illustrated through detailed case studies.

How to manage coronary artery disease in TAVI candidates?

Why should laser atherectomy be part of your complex PCI algorithm?

21 May 2025 – From EuroPCR 2025

Watch this EuroPCR 2025 session to see how ELCA can make the difference in two challenging cases: a severely calcified, undilatable lesion, and an uncrossable one. Learn how pre- and peri-procedural imaging (CT, IVUS, OCT) supports tailored decision-making, and how ELCA enables safe and effective lesion...

Why should laser atherectomy be part of your complex PCI algorithm?

Role of imaging in ACS: from non-invasive to invasive investigations

20 May 2025 – From EuroPCR 2025

Explore the critical role of imaging in acute coronary syndrome (ACS) from non-invasive coronary CT angiography to invasive intracoronary imaging modalities. This session covers detection of culprit lesions, diagnostic strategies, and PCI optimization through real-world case examples.

Role of imaging in ACS: from non-invasive to invasive investigations

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

21 May 2025 – From EuroPCR 2025

Discover the latest on managing coronary microvascular dysfunction (CMD) with insights from EuroPCR 2025. This session explores how physiology testing helps identify CMD endotypes in the cathlab and highlights the limitations of ETT for patients experiencing angina or dyspnea at rest. Learn about the A-FLUX coronary...

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

Mitral hotline: new devices

20 May 2025 – From EuroPCR 2025

Stay updated on emerging devices in mitral valve repair and replacement with this session covering novel technologies including transcatheter edge-to-edge repair (TEER), posterior leaflet restoration, transfemoral mitral annuloplasty, and a first-in-human transseptal TMVR system. Clinical trial data and early feasibility experiences provide valuable insights into advancing...

Mitral hotline: new devices

Getting started with a renal denervation programme

20 May 2025 – From EuroPCR 2025

Begin your renal denervation program with this comprehensive session focusing on the importance of a multidisciplinary hypertension team, procedural techniques with current devices, and expected clinical outcomes across patient subgroups. Practical case examples illustrate effective team-based hypertension management and procedural execution.

Getting started with a renal denervation programme

From crossroads to crossovers: cracking the left main code

20 May 2025 – From EuroPCR 2025

Navigate complex scenarios in left main coronary artery interventions with this session focusing on protected left main and multivessel disease, IVUS-guided PCI, stent optimization, and in-stent restenosis management. Real-world cases from Azerbaijan, Moldova, and Iraq provide collaborative insights and innovative strategies for challenging coronary anatomy.

From crossroads to crossovers: cracking the left main code

Strategic decision in stent failure

20 May 2025 – From EuroPCR 2025

Explore strategic decision-making in cases of stent failure in this session presenting complex clinical scenarios. Through detailed case analyses, including challenging left main trifurcation lesions and NSTEMI in the presence of chronic total occlusions, discover treatment approaches and key learnings to optimize patient outcomes.

Strategic decision in stent failure

STEMI - What if a culprit lesion is not identifiable?

20 May 2025 – From EuroPCR 2025

Address challenging STEMI cases where culprit lesions are not immediately identifiable. This session emphasizes the utility of intravascular imaging in guiding decision-making and optimizing percutaneous interventions through illustrative cases involving left main stenosis, ambiguous culprit lesions, and etiological dilemmas in coronary occlusion.

STEMI - What if a culprit lesion is not identifiable?

CTO PCI with Asian flavour

20 May 2025 – From EuroPCR 2025

Learn contemporary tips and tricks for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) with an emphasis on specific algorithms to enhance procedural efficiency and safety. This session addresses overcoming obstacles in antegrade and retrograde approaches and managing potential complications through real-world case examples.

CTO PCI with Asian flavour

Novel tools and strategies for acute heart failure

20 May 2025 – From EuroPCR 2025

Explore novel mechanical circulatory support tools and strategies for acute heart failure management, including venoarterial ECMO with a customizable counter-pulsatile ventricular assist device, advanced Impella positioning techniques, mitral TEER for cardiogenic shock with mitral regurgitation, and the interplay between vasoactive and mechanical support in ischemic cardiogenic...

Novel tools and strategies for acute heart failure
Didn’t find what you were looking for?